击败Xkr8可以通过调节瘤免疫微环境来提高化疗疗效
Yuang Chen1, Chien-Yu Chen1, Haozhe Huang1
1Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
用化疗准Xkr8可以增强抗瘤免疫力,克服抗药性. Xkr8 Knockdown促进免疫细胞死亡和有利的T细胞分化,提供了一个有前途的癌症治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 斯克兰布酶Xk相关蛋白8 (Xkr8) 调节在亡过程中酸丁素 (PS) 外化.
- Xkr8在瘤免疫抑制和化疗免疫抵抗方面发挥着关键作用.
研究的目的:
- 为了评估Xkr8向与化疗相结合在一个ortotopic模型.
- 使用单细胞RNA测序 (scRNA-seq) 阐明底层机制.
主要方法:
- 利用一个正确的胰腺瘤模型.
- 采用了Xkr8小干扰RNA (siRNA) 和5-甲 (5-Fu) /氧白金 (FuOXP) 结合物.
- 进行了深入的单细胞RNA测序 (scRNA-seq) 和轨迹分析.
主要成果:
- 通过损害细胞缩清除,Xkr8敲击诱导免疫细胞死亡 (ICD).
- 组合疗法在瘤微环境 (TME) 中增加了NK细胞和巨细胞,证明了显著的治疗疗效.
- 单细胞分析显示CD8+ T细胞对细胞毒性表型的增强分化.
结论:
- 与化疗相结合的Xkr8 Knockdown可以增强抗瘤免疫反应.
- 这种策略克服了化疗免疫抵抗,并显示出治疗各种癌症的潜力.
- 向Xkr8调节瘤微环境 (TME),以促进抗瘤免疫反应.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
